Ross Margulies Previews 2024 AMCP Annual Conference
April 10th 2024Legal expert in health care, partner, and cochair of the health care coverage and reimbursement practice at Foley Hoag LLP, Ross Margulies discusses his excitement and expectations as a featured speaker at the upcoming 2024 AMCP Annual Conference.
Read More
Four studies were highlighted that amplified the 3 components of using genetic testing in cancer treatment and prevention: (1) understanding the germline component of a tumor test, (2) broadening access to genetic counselors with video sessions, and (3) making sure risk assessment of each patient is accurate, so that patients do not have unnecessary surgeries.
Read More
COVID-19 and Cancer: NCI's Sharpless Says COVID-19 Could Halt Streak of US Cancer Mortality Gains
July 19th 2020The talk by Ned Sharpless, MD, director of the National Cancer Institute, preceded presentations on some of the earliest findings about the effects of COVID-19 on cancer: It appears that patients treated with chemotherapy for lung or thoracic cancer shortly before being diagnosed with COVID-19 face a higher risk of death, and so do patients with cancer who take the combination of hydroxychloroquine (HCQ) and azithromycin.
Read More
Apixaban, Dalteprin Shown to Have Same Bleeding Risk in Patients With Cancer
March 29th 2020Results of a study comparing apixaban with low-molecular-weight heparin as a treatment to prevent recurrent blood clots in patients with cancer may assuage some of the concern about the bleeding risk associated with direct-acting oral anticoagulants.
Read More